Temporal mineralocorticoid receptor activation regulates the molecular clock and transcription of cardiovascular disease modulators in myeloid cells

Seamus Heanue(Baker Heart and Diabetes Institute), Morag J. Young(Baker Heart and Diabetes Institute), Monica Kanki(Baker Heart and Diabetes Institute), Graeme I. Lancaster(RMIT University), Timothy J. Cole(Discovery Institute), James J. Morgan(California Institute of Technology), Judy Ng(Australian Regenerative Medicine Institute), David Ray(Oxford Centre for Diabetes, Endocrinology and Metabolism)
American Journal of Physiology-Heart and Circulatory Physiology
April 24, 2025
10.1152/ajpheart.00415.2024
Cited by 1

Related Papers

Genome-wide association study identifies genetic loci for self-reported habitual sleep duration supported by accelerometer-derived estimates
|Nature Communications|2019|652
Exosome-dependent Trafficking of HSP70
|Journal of Biological Chemistry|2005|533
Biological and clinical insights from genetics of insomnia symptoms
|Nature Genetics|2019|417
Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force
|Annals of the Rheumatic Diseases|2016|331
Deletion of Mineralocorticoid Receptors From Macrophages Protects Against Deoxycorticosterone/Salt-Induced Cardiac Fibrosis and Increased Blood Pressure
|Hypertension|2009|294